Biosimilars Portfolio

About Aurobindo Pharma

Aurobindo Pharma Limited is a vertically integrated pharmaceutical company founded in 1986, headquartered in Hyderabad, India. The company has established itself as a major player in the global generics market with a diverse portfolio spanning antibiotics, ARVs, CVS, CNS, gastroenterology, and other therapeutic segments. With multiple manufacturing facilities across India, the US, and other countries, Aurobindo has built a robust supply chain and regulatory compliance framework serving both developed and emerging markets.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi is a publicly traded Spanish pharmaceutical company with a dual business model combining proprietary drug development and contract manufacturing. The company has demonstrated significant growth, reporting €743.5 million in operating revenue for 2025, driven by its specialty pharmaceuticals and CDMO segments. Rovi is strategically investing in R&D, with expenses increasing 47% in 2025, and has established key international partnerships, including a major collaboration with Roche. Its operations span over 60 countries, supported by four manufacturing plants.

Therapeutic Areas